Akumin Inc
TSX:AKU
Relative Value
There is not enough data to reliably calculate the relative value of AKU.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
AKU Competitors Multiples
Akumin Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Akumin Inc
TSX:AKU
|
48m CAD | 0 | -0.2 | 8.6 | 24.9 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
95.1B USD | 0.2 | 53.8 | 13.8 | 13.8 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.1B EUR | 0.3 | 13.3 | 7.8 | 9.9 | |
| US |
|
Cigna Corp
NYSE:CI
|
69.4B USD | 0.3 | 11.7 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.1B EUR | 1.1 | 20.7 | 9.7 | 14.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.4B EUR | 1.2 | 23.9 | 9.2 | 17 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.2B USD | 1.6 | 25.4 | 12.2 | 17.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.8B USD | 2 | 22.1 | 12 | 16.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.2B EUR | 0.6 | 11.5 | 5.5 | 10.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.6B USD | 11.8 | -27.9 | -30.5 | -27.7 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0.8 | 13.8 | 7.1 | 9.7 |